Comparison

Anti-BCAS1 / NABC1 Antibody (34017) - 100 µg

Item no. LEIN-34017-100ug
Manufacturer Leinco Technologies
Amount 100 ug
Category
Type Antibody Primary
Applications WB, IHC
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Category
Antibody Products>Cancer Research Antibodies|Primary Monoclonal Antibodies|Products
Manufacturer - Targets
BCAS1 / NABC1
Shipping Temperature
Next Day 2 - 8°C
Storage Conditions
This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze- thaw cycles.
Product Description
Breast Carcinoma Amplified Sequence 1 (BCAS1), also known as Novel Amplified in Breast Cancer 1 (NABC1) was isolated from a region at 20q13 and is amplified in several tumor types. It is associated with more aggressive tumor phenotypes. BCAS1/NABC1 is highly expressed in some, but not all, breast cancer cell lines and in some breast tumors at 20q13.2. The BCAS1/NABC1 gene is predicted to encode a protein of 584 amino acids with no significant homology to other proteins.
Manufacturer - Research Area
Cancer Research
Concentration
Lot Specific
Formulation
PBS, pH 7.4.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close